Principal Investigator
Carlos A Zarate, M.D.
National Institute of Mental Health (NIMH)
- 12 trials
- 4 recruiting now
- 2 compounds
Therapeutic focus
- Suicide
- Depressive Disorder, Treatment-Resistant
- Ketamine
- Molecular Mechanisms of Pharmacological Action
- Neurotransmitter Agents
- Excitatory Amino Acid Agents
- Physiological Effects of Drugs
- Depressive Disorder, Major
- Depressive Disorder
- Depression
- Mental Disorders
- Mood Disorders
Recruiting now (4)
| NCT | Phase | Status | Compound | Sponsor |
|---|---|---|---|---|
| NCT06511908 | Phase 2 | Recruiting | — | National Institute of Mental Health (NIMH) |
| NCT03973268 | Phase 1 | Recruiting | — | National Institute of Mental Health (NIMH) |
| NCT03065335 | Phase 1 | Recruiting | — | National Institute of Mental Health (NIMH) |
| NCT02543983 | Phase 2 | Recruiting | — | National Institute of Mental Health (NIMH) |
All trials (12)
| NCT | Phase | Status | Compound | Sponsor |
|---|---|---|---|---|
| NCT06511908 | Phase 2 | Recruiting | — | National Institute of Mental Health (NIMH) |
| NCT03973268 | Phase 1 | Recruiting | — | National Institute of Mental Health (NIMH) |
| NCT03065335 | Phase 1 | Recruiting | — | National Institute of Mental Health (NIMH) |
| NCT02543983 | Phase 2 | Recruiting | — | National Institute of Mental Health (NIMH) |
| NCT04821271 | Phase 2 | Discontinued | TS-161 | Taisho Pharmaceutical Co., Ltd. |
| NCT02484456 | Phase 2 | Completed | AV-101 (L-4-chlorokynurenine) | National Institute of Mental Health (NIMH) |
| NCT02049385 | Phase 1/2 | Discontinued | — | National Institute of Mental Health (NIMH) |
| NCT00088699 | Phase 1/2 | Completed | — | National Institute of Mental Health (NIMH) |
| NCT00086307 | Phase 2 | Completed | — | National Institute of Mental Health (NIMH) |
| NCT00078715 | Phase 2 | Completed | — | National Institute of Mental Health (NIMH) |
| NCT00055575 | Phase 2 | Discontinued | — | National Institute of Mental Health (NIMH) |
| NCT00054704 | Phase 2 | Discontinued | — | National Institute of Mental Health (NIMH) |
Compounds studied
Trial sites (1)
- Bethesda, Maryland, United States
Investigator and site data mirrored fromClinicalTrials.gov (public domain).